Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
15,366
-3,091
-17% -$473K 0.15% 98
2025
Q4
$3.28M Buy
18,457
+897
+5% +$162K 0.2% 79
2025
Q3
$3.2M Buy
17,560
+250
+1% +$40.5K 0.2% 80
2025
Q2
$2.36M Buy
17,310
+2,032
+13% +$238K 0.16% 99
2025
Q1
$1.29M Buy
15,278
+1,329
+10% +$117K 0.1% 128
2024
Q4
$1.05M Buy
13,949
+764
+6% +$44.5K 0.08% 141
2024
Q3
$490K Buy
13,185
+58
+0.4% +$1.78K 0.04% 243
2024
Q2
$399K Buy
+13,127
New +$296K 0.04% 277

Other funds holding PLTR

Keel Point's PLTR Position: Q1 2026 in Review

Keel Point reduced its Palantir (PLTR) stake by 17% in Q1 2026, selling an estimated $473K and leaving 15,366 shares worth $2.25M. The position accounts for 0.15% of the portfolio, ranked #98.

Keel Point first reported a position in PLTR in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.28M in Q4 2025. 2,977 funds tracked by Wall St. Rank hold PLTR as of Q1 2026.

  • Keel Point held 15,366 shares of Palantir worth $2.25M as of Q1 2026.
  • Keel Point sold 3,091 Palantir shares in Q1 2026, an estimated $473K.
  • Palantir made up 0.15% of Keel Point's portfolio in Q1 2026, its #98 holding.
  • Keel Point first reported a position in Palantir in Q2 2024 and has held it in 8 quarters since.
  • Keel Point's Palantir position peaked at $3.28M in Q4 2025.
  • 2,977 funds tracked by Wall St. Rank held Palantir as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.